Published October 13, 2022
| Version v1
Book
Open
Role of Biomarkers in Risk, Diagnosis, Response to Treatment, and Prognosis of the Autoimmune Diseases
Authors/Creators
-
Moghadam Fard, Atousa
-
Ghalamkarpour, Nogol
-
Babazadeh, Arta
-
Nikseresht, Hessam
-
Feyzmanesh, Arghavan
-
Soltani, Roshanak
-
Alinejad, Erfan
-
Shahidifar, Samaneh
-
Mogharari, Zahra
-
Haddadi, Ra'na
-
Asadi, Fatemeh
-
Zafarjafarzadeh, Nikta
-
Sheikhi, Negar
-
Akhtari Kohnehshahri, Ata
-
Momeni, Zahra
-
Ranjbar, Omid
-
Ahmadianpour, Mohammad Vahid
-
Taheri, Fatemeh
Description
Over the past three decades, many methods have been developed to evaluate levels of biomarkers in autoimmune diseases. Early investigations have shown that some biomarkers are increased during active phases of the autoimmune diseases compared to healthy controls. Furthermore, it has been shown that there are some positive associations between some biomarkers and the severity of the autoimmune diseases. Moreover, managements with higher efficacies have also been shown to reduce levels of biomarkers in autoimmune diseases. Therefore, in this book we aimed to discuss the role of biomarkers in risk, diagnosis, response to treatment, and prognosis of the autoimmune diseases.